Retinal anti-VEGF regimens requiring frequent monitoring generate indirect patient costs that often outweigh direct expenses ...

Edward Machtinger, M.D., of UCSF says most mental illness and substance use trace back to trauma, and clinics that ignore this can retraumatize patients.

Management tools are intensifying across markets, including more prior authorization, step therapy, formulary exclusions, and biosimilar preferencing, with spillover from Part D into commercial ...

For individuals living with chronic conditions, stable housing enables consistent care. Conversely, housing instability can disrupt care continuity, increase financial strain, and contribute to ...

Plozasiran achieved median triglyceride reductions of 79% (SHASTA-3) and 81% (SHASTA-4) at month 12, materially exceeding placebo’s ~27% reduction. A prespecified pooled analysis demonstrated ...

Multidisciplinary clinic-team adjudication found mental illness and substance use each contributed to 58% of deaths, yet death certificates documented them in 5% and 13%, respectively. HIV was listed ...

Survey responses (166/708 partners) showed 52% had ≥1 award canceled, 81% were asked to restrict activities, and 3% closed permanently. PEPFAR prevention spending was reported to drop 51% from 2024 to ...

Cohort data showed A1C disparities by race/ethnicity, with higher A1C in Black participants versus White non-Hispanic peers despite comparable diabetes technology use. Pump therapy combined with CGM ...

Linkage of a large birth cohort to a national psychiatric registry enabled long-horizon ascertainment of schizophrenia outcomes and consistent exposure definition among Holocaust-exposed parents.

A cohort of 8,502 insulin-treated adults across 18 primary care clinics included 28.1% prescribed CGM; many had Medicare or Medicaid coverage, with Medicaid coverage supporting CGM access in New York.